ArticleBehavioral sciences (Basel, Switzerland)2020
Role of Metacognition Thinking and Psychological Traits in Breast Cancer Survivorship.
Article in Behavioral sciences (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 11 citations in OpenAlex.
- Digital Innovation in Oncological Primary Treatment for Well-Being of Patients: Psychological Caring as Prompt for Enhancing Quality of Life.Current oncology (Toronto, Ont.) · 2021Trial
- AI Use in Mammography for Diagnosing Metachronous Contralateral Breast Cancer.Journal of imaging · 2024Article
- A chain mediation model reveals the association between metacognition and quality of life in hematologic tumor patients.Scientific reports · 2024Article
- Experiences of Female Breast Cancer Survivors Concerning Their Return to Work in Spain.Behavioral sciences (Basel, Switzerland) · 2021Article
- Perceived Causes of Cancer and Corresponding Behavioral Changes: A Qualitative Study on Breast Cancer Survivors in Taiwan.Cancer control : journal of the Moffitt Cancer CenterArticle
- The relationships among health-promoting lifestyle behaviors and perceived stress in women with early-stage breast cancer over 2 years.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Longer survivorship is possible due to advances enabling early detection and treatment. However, cancer survivors are faced with prognostic uncertainty regarding survival, long-term symptoms, surveillance, and consequences of treatment. This study aimed at investigating emotional traits of women after breast cancer (BC) diagnosis from a three-year perspective of the disease. We intended to examine the emotional trend within longer survivorship after the primary treatment for BC. A sample of 72 women diagnosed with breast cancer (age range 30-55 years) was evaluated based on metacognition (Metacognitive Questionnaire-30 test), psychological distress (Psychological Distress Inventory test), anxiety, stress, and depression (Depression, Anxiety and Stress Scale-21 test). The data analysis applied was descriptive analysis, ANOVA, MANOVA, and ANCOVA comparing MCQ-30 variables and psychological traits (PDI, DASS-21). The results indicated positive recovery after primary care despite emotional fragility in survivorship owing to negative thoughts; correlations among metacognitive factors, anxiety, and distress not only confirmed the negative emotional pattern just after primary care, but also showed women regaining a positive emotional pattern in daily life. The survivors exhibited emotional fragility during certain specific points of time during the course of their survivorship. Based on our findings, the fear of recurrence and cancer-specific psychological treatment is a better framework to boost and improve clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.